Timothy C Durazzo1, Dieter J Meyerhoff2, Anderson Mon2, Christoph Abé2, Stefan Gazdzinski2, Donna E Murray2. 1. Center for Imaging of Neurodegenerative Diseases, San Francisco Veterans Administration Medical Center, San Francisco, California.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.. Electronic address: timothy.durazzo@ucsf.edu. 2. Center for Imaging of Neurodegenerative Diseases, San Francisco Veterans Administration Medical Center, San Francisco, California.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Abstract
BACKGROUND: Cigarette smoking is associated with metabolite abnormalities in anterior brain regions, but it is unclear if these abnormalities are apparent in other regions. Additionally, relationships between regional brain metabolite levels and measures of decision making, risk taking, and impulsivity in smokers and nonsmokers have not been investigated. METHODS: In young to middle-aged (predominately male) nonsmokers (n = 30) and smokers (n = 35), N-acetylaspartate (NAA), choline-containing compounds, creatine-containing compounds (Cr), myo-inositol (mI), and glutamate (Glu) levels in the anterior cingulate cortex and right dorsolateral prefrontal cortex (DLPFC) were compared via 4-tesla proton single volume magnetic resonance spectroscopy. Groups also were compared on NAA, choline-containing compounds, Cr, and mI concentrations in the gray matter and white matter of the four cerebral lobes and subcortical nuclei/regions with 1.5-tesla proton magnetic resonance spectroscopy. Associations of regional metabolite levels with neurocognitive, decision-making, risk-taking, and self-reported impulsivity measures were examined. RESULTS: Smokers showed lower DLPFC NAA, Cr, mI and Glu concentrations and lower lenticular nuclei NAA level; smokers also demonstrated greater age-related decreases of DLPFC NAA and anterior cingulate cortex and DLPFC Glu levels. Smokers exhibited poorer decision making and greater impulsivity. Across the sample, higher NAA and Glu in the DLPFC and NAA concentrations in multiple lobar gray matter and white matter regions and subcortical nuclei were associated with better neurocognition and lower impulsivity. CONCLUSIONS: This study provides additional novel evidence that chronic smoking in young and middle-aged individuals is associated with significant age-related neurobiological abnormalities in anterior frontal regions implicated in the development and maintenance of addictive disorders.
BACKGROUND: Cigarette smoking is associated with metabolite abnormalities in anterior brain regions, but it is unclear if these abnormalities are apparent in other regions. Additionally, relationships between regional brain metabolite levels and measures of decision making, risk taking, and impulsivity in smokers and nonsmokers have not been investigated. METHODS: In young to middle-aged (predominately male) nonsmokers (n = 30) and smokers (n = 35), N-acetylaspartate (NAA), choline-containing compounds, creatine-containing compounds (Cr), myo-inositol (mI), and glutamate (Glu) levels in the anterior cingulate cortex and right dorsolateral prefrontal cortex (DLPFC) were compared via 4-tesla proton single volume magnetic resonance spectroscopy. Groups also were compared on NAA, choline-containing compounds, Cr, and mI concentrations in the gray matter and white matter of the four cerebral lobes and subcortical nuclei/regions with 1.5-tesla proton magnetic resonance spectroscopy. Associations of regional metabolite levels with neurocognitive, decision-making, risk-taking, and self-reported impulsivity measures were examined. RESULTS: Smokers showed lower DLPFC NAA, Cr, mI and Glu concentrations and lower lenticular nuclei NAA level; smokers also demonstrated greater age-related decreases of DLPFC NAA and anterior cingulate cortex and DLPFC Glu levels. Smokers exhibited poorer decision making and greater impulsivity. Across the sample, higher NAA and Glu in the DLPFC and NAA concentrations in multiple lobar gray matter and white matter regions and subcortical nuclei were associated with better neurocognition and lower impulsivity. CONCLUSIONS: This study provides additional novel evidence that chronic smoking in young and middle-aged individuals is associated with significant age-related neurobiological abnormalities in anterior frontal regions implicated in the development and maintenance of addictive disorders.
Authors: C W Lejuez; Jennifer P Read; Christopher W Kahler; Jerry B Richards; Susan E Ramsey; Gregory L Stuart; David R Strong; Richard A Brown Journal: J Exp Psychol Appl Date: 2002-06
Authors: Arthur L Brody; Mark A Mandelkern; Murray E Jarvik; Grace S Lee; Erlyn C Smith; Joe C Huang; Robert G Bota; George Bartzokis; Edythe D London Journal: Biol Psychiatry Date: 2004-01-01 Impact factor: 13.382
Authors: Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee Journal: Sci Transl Med Date: 2011-09-28 Impact factor: 17.956
Authors: Jürgen Gallinat; Undine E Lang; Leslie K Jacobsen; Malek Bajbouj; Peter Kalus; Dorothea von Haebler; Frank Seifert; Florian Schubert Journal: J Clin Psychopharmacol Date: 2007-02 Impact factor: 3.153
Authors: D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: Timothy C Durazzo; Anderson Mon; David Pennington; Christoph Abé; Stefan Gazdzinski; Dieter J Meyerhoff Journal: Addict Biol Date: 2012-09-03 Impact factor: 4.280
Authors: Timothy C Durazzo; Kent E Hutchison; Susanna L Fryer; Anderson Mon; Dieter J Meyerhoff Journal: Front Pharmacol Date: 2012-10-11 Impact factor: 5.810
Authors: Allison S Brandt; Paul G Unschuld; Subechhya Pradhan; Issel Anne L Lim; Gregory Churchill; Ashley D Harris; Jun Hua; Peter B Barker; Christopher A Ross; Peter C M van Zijl; Richard A E Edden; Russell L Margolis Journal: Schizophr Res Date: 2016-02-28 Impact factor: 4.939
Authors: Timothy C Durazzo; Magdalena Korecka; John Q Trojanowski; Michael W Weiner; Ruth O' Hara; John W Ashford; Leslie M Shaw Journal: J Alzheimers Dis Date: 2016-07-25 Impact factor: 4.472
Authors: Drew A Torigian; Judith Green-McKenzie; Xianling Liu; Frances S Shofer; Thomas Werner; Catherine E Smith; Andrew A Strasser; Mateen C Moghbel; Ami H Parekh; Grace Choi; Marcus D Goncalves; Natalie Spaccarelli; Saied Gholami; Prithvi S Kumar; Yubing Tong; Jayaram K Udupa; Clementina Mesaros; Abass Alavi Journal: Acad Radiol Date: 2016-10-18 Impact factor: 3.173
Authors: Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Hongji Chen; Andrew A Maudsley; Sulaiman Sheriff; Shuo Chen; Anya Savransky; Wyatt Marshall; Meghann C Ryan; Heather A Bruce; Alan R Shuldiner; Braxton D Mitchell; Peter Kochunov; L Elliot Hong Journal: Proc Natl Acad Sci U S A Date: 2019-11-21 Impact factor: 11.205
Authors: Christian Stefan Legind; Brian Villumsen Broberg; René Christiaan William Mandl; Rachel Brouwer; Simon Jesper Anhøj; Rikke Hilker; Maria Høj Jensen; Philip McGuire; Hilleke Hulshoff Pol; Birgitte Fagerlund; Egill Rostrup; Birte Yding Glenthøj Journal: Neuropsychopharmacology Date: 2018-10-09 Impact factor: 7.853
Authors: Bianca Jupp; Steve J Sawiak; Bastiaan van der Veen; Suzanne Lemstra; Chiara Toschi; Rebecca L Barlow; Anton Pekcec; Tom Bretschneider; Janet R Nicholson; Trevor W Robbins; Jeffrey W Dalley Journal: Cereb Cortex Date: 2020-05-14 Impact factor: 5.357